SCHEMBL25979849

SCHEMBL25979849

c1ccc(-c2ccc(N(c3ccccc3)c3ccc4c(c3)oc3cc(-c5cc(-c6ccc7ccccc7c6)nc(-c6ccccc6)n5)ccc34)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.43
CYP1B1 Q16678 1/20 0.43
MEN1 O00255 7/20 0.39
KMT2A Q03164 7/20 0.39
ALDH1A1 P00352 5/20 0.39
CYP1A2 P05177 4/20 0.39
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HPGD P15428 4/20 0.37
MAPT P10636 4/20 0.37
NTSR1 P30989 1/20 0.37
LMNA P02545 2/20 0.36
GLA P06280 1/20 0.36
CTRC Q99895 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RAC1 P63000 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979869 0.98 CYP1A1 (0.46) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25979364 0.94 CYP1A1 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL26779281 0.94 ALDH1A1 (0.42) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25979783 0.94 ALDH1A1 (0.42) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25979930 0.93 CYP1A2 (0.41) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25979844 0.93 MEN1 (0.43) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25979825 0.93 MEN1 (0.43) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25979846 0.93 MEN1 (0.43) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25979801 0.93 CYP1A2 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25979388 0.92 CYP1A1 (0.43) CYP1A1CYP1B1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 CYP1A1 2/4885CYP1B1 3/4885MEN1 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.